IBO PE Ratio & Valuation,Is IBO Overvalued

IBO Relative Valuation

IBO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IBO is overvalued; if below, it's undervalued.

Historical Valuation

Impact Biomedical Inc (IBO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Impact Biomedical Inc (IBO) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：0.49

Fair

0.00

EV/EBITDA

Impact Biomedical Inc. (IBO) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.00

EV/EBIT

Impact Biomedical Inc. (IBO) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.

0.00

Impact Biomedical Inc. (IBO) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

0.00

P/OCF

Impact Biomedical Inc. (IBO) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Impact Biomedical Inc. (IBO) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Impact Biomedical Inc (IBO) has a current Price-to-Book (P/B) ratio of -0.50. Compared to its 3-year average P/B ratio of 0.61 , the current P/B ratio is approximately -181.15% higher. Relative to its 5-year average P/B ratio of 0.61, the current P/B ratio is about -181.15% higher. Impact Biomedical Inc (IBO) has a Forward Free Cash Flow (FCF) yield of approximately -7.95%. Compared to its 3-year average FCF yield of -37.11%, the current FCF yield is approximately -78.57% lower. Relative to its 5-year average FCF yield of -37.11% , the current FCF yield is about -78.57% lower.

-0.50

P/B

Median3y

0.61

Median5y

0.61

-7.95

FCF Yield

Median3y

-37.11

Median5y

-37.11

Competitors Valuation Multiple

The average P/S ratio for IBO's competitors is 0.12, providing a benchmark for relative valuation. Impact Biomedical Inc Corp (IBO) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of IBO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of IBO in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Impact Biomedical Inc (IBO) currently overvalued or undervalued?

What is Impact Biomedical Inc (IBO) fair value?

IBO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Impact Biomedical Inc (IBO) is between to according to relative valuation methord.

How does IBO's valuation metrics compare to the industry average?

The average P/S ratio for IBO's competitors is 0.12, providing a benchmark for relative valuation. Impact Biomedical Inc Corp (IBO) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Impact Biomedical Inc (IBO) as of Dec 15 2025?

As of Dec 15 2025, Impact Biomedical Inc (IBO) has a P/B ratio of -0.50. This indicates that the market values IBO at -0.50 times its book value.

What is the current FCF Yield for Impact Biomedical Inc (IBO) as of Dec 15 2025?

As of Dec 15 2025, Impact Biomedical Inc (IBO) has a FCF Yield of -7.95%. This means that for every dollar of Impact Biomedical Inc’s market capitalization, the company generates -7.95 cents in free cash flow.

What is the current Forward P/E ratio for Impact Biomedical Inc (IBO) as of Dec 15 2025?

As of Dec 15 2025, Impact Biomedical Inc (IBO) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Impact Biomedical Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Impact Biomedical Inc (IBO) as of Dec 15 2025?

As of Dec 15 2025, Impact Biomedical Inc (IBO) has a Forward P/S ratio of 0.00. This means the market is valuing IBO at $0.00 for every dollar of expected revenue over the next 12 months.

IBO Valuation

IBO Valuation

IBO Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is Impact Biomedical Inc (IBO) currently overvalued or undervalued?

What is Impact Biomedical Inc (IBO) fair value?

How does IBO's valuation metrics compare to the industry average?

What is the current P/B ratio for Impact Biomedical Inc (IBO) as of Dec 15 2025?

What is the current FCF Yield for Impact Biomedical Inc (IBO) as of Dec 15 2025?

What is the current Forward P/E ratio for Impact Biomedical Inc (IBO) as of Dec 15 2025?

What is the current Forward P/S ratio for Impact Biomedical Inc (IBO) as of Dec 15 2025?